Shark Tank's Daymond John visits the NYSE for the 94th annual tree lighting. He stops by Cheddar to discuss his favorite deals from the year and the best business advice he's ever received.
John says that when an entrepreneur pitches on Shark Tank, he looks for someone who would work on their idea and company without being paid. He values passion and determination and uses that as an indicator of success.
"They tell us about all the mistakes they made, they have a passion about it," he tells Cheddar. "I feel like the train is gonna leave whether I'm on it or not. They know their customer very well, so they're not using my money as tuition....and I have to like the person."
John looked back on some of his Shark Tank deals. He explains his decision behind his deal with Moziah Bridges of Mo's Bows. Initially, Moziah pitched the Sharks on $50,000 in exchange for 20%. John came back and told him not to take any money, and instead to accept his offer of mentorship.
John explained to Cheddar that he received a similar offer when he was starting his clothing company, FUBU, and it proved to be incredibly helpful and lucrative.
Some House Democrats will have to vote for McCarthy's bill if enough conservative Republicans keep their word to oppose any compromise.
Blue Bird, a maker of school buses, opened up a production facility to meet the rising demand for electric school buses.
The National Eating Disorders Association said it's replacing its staff with an artificial intelligence chatbot.
Hyundai and LG announced a partnership to build a $4.3 billion electric battery plant in Georgia.
JPMorgan announced job cuts at First Republic Bank, a month after acquiring the company.
AstraZeneca said its cancer-treatment drugs when used following chemotherapy treatment showed positive late-stage trial results for endometrial cancer patients.
The federal government is giving away for free some historic lighthouses and is also auctioning some of them off too.
The Week's Top Stories is a guided tour through the biggest market stories of the week, from winning stocks to brutal dips to the facts and forecasts generating buzz on Wall Street.
Elon Musk's brain-implant company Neuralink said it received approval from the Food and Drug Administration to begin human clinical trials.
Aileen Del Cid, head of marketing at Samsung TV Plus, sat down with Cheddar News reporter Michelle Castillo to discuss the platform's plans to stand out from the streaming competition with a new channel featuring Conan O'Brien.
